Vencor International Retains The Haft Group, Inc.

BEVERLY HILLS, Calif. -- Vencor International (Pink Sheets:VNCO) announced today that it has retained the services of The Haft Group, Inc., Manhattan based investor and public relations consultants. Mr. Haft has enjoyed a renowned career spanning 30 years as a leading specialist in investor and public relations, representing a wide variety of United States and Canadian publicly traded companies. "The Haft Group will provide investor and corporate communications services to Wall Street markets and act as liaisons to Vencor shareholders. Because of Mr. Haft's background in both Wall Street and corporate communities he will work with us in creating strategic alliances with the firms in the investment banking area," stated David Harkham, Vencor International CEO.

Mr. Haft was previously a partner and principal of two NYSE member firms, which have since merged with other entities. His business career also includes serving as senior vice president-public relations for the then Warner Communications, and earlier, director of public relations for Esquire and GQ Magazines.

Commenting on current trends in investor and public relations, Mr. Haft states, "Far too many emerging public companies with strong fundamentals and compelling strategies are not receiving the appropriate attention they deserve within the increasingly competitive financial marketplace. Public companies must be proactive in providing timely and consistent communications to both financial markets and with company shareholders effectively and economically."

Mr. Haft, a graduate of Syracuse University, and the Yale Graduate School, has served on the board of directors of several public companies. He is a founder of The Albert Einstein College of Medicine, in New York. He is a member of several professional organizations, including the Public Relations Society of America, Zeta Beta Tau Fraternity, and the Friars Club.

About Vencor

Vencor International is a global manufacturer and distributor of molecular and immunoassay diagnostics technologies and healthcare products and services. Vencor distributes the only FDA Approved at-home diagnostic products for HIV and Hepatitis C among others at www.athomediagnostics.com as well as infectious disease Rapid Tests to the emerging healthcare markets of the world. http://www.vencorinternational.com/products_overview.html.

Vencor recently expanded into the manufacturing and distribution of healthcare apparel and materials to primary US and international markets.

Safe Harbor Statement

The information contained in this press release, including "forward-looking statements" within section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 contained herein, should be reviewed in conjunction with the company's annual report, financial filings and other publicly available information regarding the company, copies of which are available from the company upon request. Such publicly available information sets forth many risks and uncertainties related to the Company's business, and such statements, including risks and uncertainties related to that, are unpredictable and outside of the influence and/or control of the company.